Insider Holders & Insider Ownership - Myovant Sciences Ltd. (MYOV)

List of insiders holdings for Myovant Sciences Ltd.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1 Sumitomo Chemical Co. Ltd.
Sumitomo Pharma Co. Ltd.
Sumitovant Biopharma Ltd.
10% Owner
2023-03-10 09:29:56 45,798,176
0
45,798,176 Form 13D
2 MILLENNIUM PHARMACEUTICALS INC
Takeda Pharmaceuticals U.S.A. Inc.
10% Owner
2018-03-29 20:50:40 7,420,625
0
7,420,625 Form 3
3 Takeda Pharmaceuticals International AG
TAKEDA PHARMACEUTICAL CO LTD
Takeda A/S
Takeda Europe Holdings B.V.
Takeda Pharma A/S
10% Owner
2020-01-24 06:16:37 3,920,625
0
3,920,625 Form 13G
4 Seely Lynn
Principal Executive Officer
2020-04-07 17:16:33 1,346,517
846,168
2,192,685 Form 4
5 Sablich Kim
Chief Commercial Officer
2020-04-07 17:14:42 281,174
0
281,174 Form 4
6 KARBE FRANK
Principal Fin'l & Accounting
2021-07-09 16:27:07 212,296
0
212,296 Form 4
7 Torti Frank
Director
2019-08-27 16:50:56 58,608
0
58,608 Form 4
8 DeVeydt Wayne S
Director
2017-10-20 16:46:51 22,500
0
22,500 Form 4
9 Altmeyer Mark
Director
2018-09-04 16:44:44 22,500
0
22,500 Form 4
10 Sebelius Kathleen
Director
2020-09-17 16:12:00 21,603
0
21,603 Form 4
11 Romeo Marianne L.
Head,Global Trans. & Risk Mgmt
2016-10-26 20:11:12 14,102
0
14,102 Form 3
12 Gulfo Adele M.
Director
2023-03-10 09:28:58 0
0
0 Form 4
13 Arjona Ferreira Juan Camilo
Chief Medical Officer
2023-03-10 09:24:59 0
0
0 Form 4
14 Curran Terrie
Director
2023-03-10 09:27:33 0
0
0 Form 4
15 GUINAN MARK
Director
2023-03-10 09:28:18 0
0
0 Form 4
16 Roivant Sciences Ltd.
10% Owner
2019-12-31 16:45:46 0
0
0 Form 4
17 Lang Matthew
General Counsel & Corp. Secy.
2023-03-10 09:29:36 0
0
0 Form 4
18 Marek David C
Principal Executive Officer
2023-03-10 09:30:13 0
0
0 Form 4
19 Mehra Uneek
Principal Financial Officer
2023-03-10 09:31:05 0
0
0 Form 4
20 Merendino Lauren
Chief Commercial Officer
2023-03-10 09:31:44 0
0
0 Form 4
21 POTTER MYRTLE S
Director
2023-03-10 09:32:18 0
0
0 Form 4
22 Valente Nancy
Director
2023-03-10 09:32:52 0
0
0 Form 4
23 Nishinaka Shigeyuki
Director
2022-10-21 17:15:29 0
0
0 Form 3
24 Nomura Hiroshi
Director
2019-12-30 17:15:03 0
0
0 Form 3
25 Lo Andrew
Former 10% Owner
2019-07-16 17:42:17 0
0
0 Form 13D
26 Machado Patrick
Former 10% Owner
2019-07-16 17:31:17 0
0
0 Form 13D
27 Dexxon Holdings Ltd.
Dexcel Pharma Technologies Ltd.
Oren Dan
See remarks
2019-07-12 16:52:12 0
0
0 Form 4
28 VIKING GLOBAL PERFORMANCE LLC
Viking Global Equities LP
Viking Global Equities II LP
VGE III Portfolio Ltd.
Viking Global Equities Master Ltd.
Viking Long Fund GP LLC
Viking Long Fund Master Ltd.
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
Former 10% Owner
2019-07-12 20:34:36 0
0
0 Form 4
29 VIKING GLOBAL INVESTORS LP
Viking Global Opportunities Illiquid Investments Sub-Master LP
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities GP LLC
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
Former 10% Owner
2019-07-12 20:33:27 0
0
0 Form 4
30 SVF Investments (UK) Ltd
SoftBank Vision Fund L.P.
SVF Holdings (UK) LLP
SVF GP (Jersey) Ltd
Former 10% Owner
2019-07-12 19:50:26 0
0
0 Form 4
31 QVT Associates GP LLC
QVT Fund V LP
10% Owner
2019-07-12 16:28:55 0
0
0 Form 4
32 VIKING GLOBAL INVESTORS LP
Viking Global Opportunities Illiquid Investments Sub-Master LP
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities GP LLC
HALVORSEN OLE ANDREAS
Ott David C.
Sundheim Daniel S.
10% Owner
2019-07-12 16:59:53 0
0
0 Form 13D
33 Ramaswamy Vivek
Director
2016-10-26 20:17:40 0
0
0 Form 3
34 MANCHESTER KEITH S
Director
2016-10-26 20:13:55 0
0
0 Form 3